“SC”的搜索结果，显示 31-40 项，共有 2954 项

1. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

2. 医疗记录和影像申请- 妙佑医疗国际

   SC: Mayo Clinic Breadcrumb. 患者与访客指南. Sections 患者与访客指南. ‏妙佑医疗国际亚利桑那州院区. Collapse ‏妙佑医疗国际亚利桑那州院区. 来到这里 · 逛院区 · 院区 ...

3. 耳鼻喉科(ENT) /头颈外科- 临床试验- 妙佑医疗国际

   SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

4. 佛罗里达州的价格透明度- 妙佑医疗国际

   SC: Mayo Clinic Breadcrumb. 主页 · 保险和账单 · 价格估算. Sections 价格估算. 抵达前. Collapse 抵达前. 患者检查表 · 服务前押金 · 登记 · 国际患者 · 常见问答 ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...